Belvedere Trading LLC Amylyx Pharmaceuticals, Inc. Transaction History

Belvedere Trading LLC

  • $74.4 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024
BUY
$12.07 - $18.46 $159,480 - $243,911
13,213 New
13,213 $194,000
Q4 2022

Feb 14, 2023
SELL
$29.75 - $39.26 $1.07 Million - $1.41 Million
-35,857 Reduced 82.43%
7,642 $282,000
Q3 2022

Oct 26, 2022
SELL
$17.15 - $30.92 $2.15 Million - $3.87 Million
-125,089 Reduced 74.2%
43,499 $1.63 Million
Q2 2022

Jul 21, 2022
BUY
$6.85 - $19.93 $1.15 Million - $3.36 Million
168,588 New
168,588 $3.52 Million

Others Institutions Holding AMLX

# of Institutions
127
Shares Held
44.4M
Call Options Held
235K
Put Options Held
530K
View Full List

About Amylyx Pharmaceuticals, Inc.

AMLX Quotes by TradingView
  • Ticker AMLX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,533,200
  • Market Cap $308M
  • Description
  • Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...
More about AMLX
Track This Portfolio

Track Belvedere Trading LLC Portfolio

Follow Belvedere Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Belvedere Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Belvedere Trading LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email